These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 22030468

  • 41. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R, Martín-Santos R, Gómez-Gil E, Martínez de Osaba MJ, Imaz ML, Gastó C.
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [Abstract] [Full Text] [Related]

  • 42. Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder.
    Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC.
    Neuropsychopharmacology; 1996 Jul; 15(1):7-15. PubMed ID: 8797187
    [Abstract] [Full Text] [Related]

  • 43. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 44. Association of amygdala volumes with cortisol secretion in unipolar depressed patients.
    Schuhmacher A, Mössner R, Jessen F, Scheef L, Block W, Belloche AC, Lennertz L, Welper H, Höfels S, Pfeiffer U, Wagner M, Maier W, Schwab S, Zobel A.
    Psychiatry Res; 2012 May 31; 202(2):96-103. PubMed ID: 22698761
    [Abstract] [Full Text] [Related]

  • 45. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G.
    J Psychiatr Res; 2007 May 31; 41(3-4):290-4. PubMed ID: 16956623
    [Abstract] [Full Text] [Related]

  • 46. Trauma exposure in relation to basal salivary cortisol and the hormone response to the dexamethasone/CRH test in male railway employees without lifetime psychopathology.
    Klaassens ER, Giltay EJ, van Veen T, Veen G, Zitman FG.
    Psychoneuroendocrinology; 2010 Jul 31; 35(6):878-86. PubMed ID: 20036072
    [Abstract] [Full Text] [Related]

  • 47. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 31; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 48. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 31; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 49. Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders.
    Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F.
    Neuropsychopharmacology; 1998 Apr 31; 18(4):253-62. PubMed ID: 9509493
    [Abstract] [Full Text] [Related]

  • 50. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 31; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 51. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.
    Psychoneuroendocrinology; 2009 Feb 31; 34(2):238-248. PubMed ID: 18926641
    [Abstract] [Full Text] [Related]

  • 52. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.
    Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M.
    J Psychiatr Res; 2003 Feb 31; 37(2):135-43. PubMed ID: 12842167
    [Abstract] [Full Text] [Related]

  • 53. Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse.
    Rinne T, de Kloet ER, Wouters L, Goekoop JG, de Rijk RH, van den Brink W.
    Neuropsychopharmacology; 2003 Jan 31; 28(1):126-32. PubMed ID: 12496948
    [Abstract] [Full Text] [Related]

  • 54. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M.
    J Psychiatr Res; 2001 Jan 31; 35(2):83-94. PubMed ID: 11377437
    [Abstract] [Full Text] [Related]

  • 55. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis.
    Himmerich H, Binder EB, Künzel HE, Schuld A, Lucae S, Uhr M, Pollmächer T, Holsboer F, Ising M.
    Biol Psychiatry; 2006 Oct 15; 60(8):882-8. PubMed ID: 16989778
    [Abstract] [Full Text] [Related]

  • 56. The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.
    Schüle C, Baghai TC, Eser D, Häfner S, Born C, Herrmann S, Rupprecht R.
    PLoS One; 2009 Oct 15; 4(1):e4324. PubMed ID: 19177168
    [Abstract] [Full Text] [Related]

  • 57. A variant of the neuronal amino acid transporter SLC6A15 is associated with ACTH and cortisol responses and cognitive performance in unipolar depression.
    Schuhmacher A, Lennertz L, Wagner M, Höfels S, Pfeiffer U, Guttenthaler V, Maier W, Zobel A, Mössner R.
    Int J Neuropsychopharmacol; 2013 Feb 15; 16(1):83-90. PubMed ID: 22475622
    [Abstract] [Full Text] [Related]

  • 58. Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls.
    Rampp C, Eichelkraut A, Best J, Czamara D, Rex-Haffner M, Uhr M, Binder EB, Menke A.
    J Psychiatr Res; 2018 Mar 15; 98():107-115. PubMed ID: 29331929
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression.
    Baghai TC, Schüle C, Zwanzger P, Minov C, Holme C, Padberg F, Bidlingmaier M, Strasburger CJ, Rupprecht R.
    Psychoneuroendocrinology; 2002 Apr 15; 27(3):385-99. PubMed ID: 11818173
    [Abstract] [Full Text] [Related]

  • 60. The oCRH stimulation test before and after clinical recovery from depression.
    Amsterdam JD, Maislin G, Winokur A, Berwish N, Kling M, Gold P.
    J Affect Disord; 1988 Apr 15; 14(3):213-22. PubMed ID: 2838538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.